The following resources can be used as a reminder for staff on the order of putting on and taking off, and reuse of PPE.
New Tests Launched in July - Insights
In July 2019, Mayo Clinic Laboratories announced six new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in September - Insights
In September 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes. In addition to these new tests, the department also announced several test changes.
A team of researchers has confirmed that neutralizing monoclonal antibody (nMAb) therapies are associated with reduced risk of adverse outcomes of COVID-19 in high-risk populations. The cohort study, published in JAMA, included more than...
Mayo Clinic Laboratories’ pharmacogenomic testing offers superior analytical quality, enabling targeted detection of more clinically actionable alleles than other testing.
November 2023 - Gastroenterology Pathology Case 2 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.
Learn how our renal genetic testing was developed by a team of experts and is among the most comprehensive diagnostic testing available.
Whole genome sequencing - Insights
Check out Mayo Clinic Laboratories’ whole genome testing, a next-generation sequencing assay that interrogates nearly every base pair of an individual’s DNA, including the mitochondrial genome.
Mayo Clinic Labs @Work: Katie Perry - Insights
Katie Perry’s work as a supervisor for the Mayo Lab Inquiry call center helps ensure that clients get the information they need, when they need it, and smooths the way for tests to be completed without delay.
Medication-targeted testing - Insights
Learn more about how medication targeted testing at Mayo Clinic Laboratories can assist in treatment optimization for medication with established pharmacogenomic associations.